date:Apr 15, 2014
rates were in line with the companys mid-term sales growth objectives. Sales in developing markets increased by 9.8% on a like-for-like basis.
Mid-term, Givaudan said that the overall objective is to grow organically between 4.5% and 5.5% per annum, assuming a market growth of 2-3%, and to continue on the path of market share gains. By delivering on the company's five-pillar growth strategy developing markets, health and wellness, market share gains with targeted customers and segments, resear